Misgav-based developer of technologies to assist clinicians in making definitive and early diagnosis of neurodegenerative diseases such as Alzheimer’s and Parkinson’s based on cellular changes that can be used as biomarkers. Completed first human feasibility trial, now preparing for large validation studies, and is seeking to collaborate with pharmaceutical companies in clinical trials. Requests connections to clinical sites and findings, investors, CROs, and individual to add to the scientific advisory board.
